An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075

Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colon...

Full description

Saved in:
Bibliographic Details
Published inJournal of bacteriology Vol. 199; no. 3; p. E00705
Main Authors Tipton, Kyle A., Rather, Philip N.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR . Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR ) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCE Acinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii , this may represent an “Achilles' heel” that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii , and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.
AbstractList Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR . Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR ) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCE Acinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii , this may represent an “Achilles' heel” that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii , and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.
Recently, a novel phase-variable colony opacity phenotype was discovered in strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator Subsequent investigation of in-frame deletions of and the sensor kinase (located adjacent to ) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in strain AB5075, but a mutation in both and produced a more profound effect. The and genes were cotranscribed but were not subject to autoregulation by OmpR. Both and mutant opaque variants were attenuated in virulence in the infection model, whereas mutation of had no effect on the virulence of the translucent variant. is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in , this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The two-component system ortholog negatively regulates phase variation in , and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.
Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR. Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCE Acinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.
Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCEAcinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCEAcinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.
Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR. Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant.
Author Rather, Philip N.
Tipton, Kyle A.
Author_xml – sequence: 1
  givenname: Kyle A.
  surname: Tipton
  fullname: Tipton, Kyle A.
  organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
– sequence: 2
  givenname: Philip N.
  surname: Rather
  fullname: Rather, Philip N.
  organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA, Research Service, Atlanta VA Medical Center, Decatur, Georgia, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27872182$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1v1DAQhi1URLcLJ-7IEhckmmI7ceJckHZXfFVFi9qlBy6W40x2XSX2YjtF-1P4t3jbUkHFAV8szzx-57VnjtCBdRYQek7JCaVMvDmdnxBSEZ7R8hGaUFKLjPOcHKAJIYxmNa3zQ3QUwhUhtCg4e4IOWSUqRgWboJ8zi92wPc_AXn_Dqx8uW6RjKmAjvtiFCANe-rhxvVvjc1iPvYoQ8JeNCoAvlTcqGmeP8TIMLhqNV64Hr6yGY_w5BXoTd8dY2RZfGj_2kBLYWDzTxkJ0jdIRPG7UOChrjcEX0at9es5JxZ-ix53qAzy726fo6_t3q8XH7Gz54dNidpbpvGIx0yxvupwXLSeqaUnBuFCc5Zy0KldlB5VuVVnRrqtJATk0rKwF1JRWtBG1EHU-RW9vdbdjM0Cr08u96uXWm0H5nXTKyL8z1mzk2l3LVKWitEgCr-4EvPs-QohyMEFD3ysLbgySilLkaYn_QZP_ui5JmdCXD9ArN3qbfmIvSIigPBmYohd_mr93_bvBCXh9C2jvQvDQ3SOUyP34yNO5vBkfSfdF6QNam3jT4n1n-n_e-QUuAcdq
CODEN JOBAAY
CitedBy_id crossref_primary_10_1111_1462_2920_14565
crossref_primary_10_3389_fcimb_2023_1053968
crossref_primary_10_1016_j_micpath_2018_12_039
crossref_primary_10_3390_ijms25073862
crossref_primary_10_3389_fmicb_2018_02459
crossref_primary_10_3390_antibiotics9030119
crossref_primary_10_1038_s42003_024_05995_z
crossref_primary_10_3389_fmicb_2020_00548
crossref_primary_10_1016_j_aquaculture_2022_738441
crossref_primary_10_3390_microorganisms8071068
crossref_primary_10_1016_j_celrep_2021_108920
crossref_primary_10_3389_fcimb_2023_1203487
crossref_primary_10_1128_iai_00023_23
crossref_primary_10_3389_fmicb_2021_764733
crossref_primary_10_1128_aac_01033_22
crossref_primary_10_3389_fmicb_2022_1032969
crossref_primary_10_1111_1758_2229_12718
crossref_primary_10_3389_fmicb_2021_653556
crossref_primary_10_2147_IDR_S380883
crossref_primary_10_1038_s41598_020_71672_w
crossref_primary_10_3390_pathogens10111483
crossref_primary_10_3390_biom10050720
crossref_primary_10_1016_j_micres_2019_126295
crossref_primary_10_1080_21505594_2022_2135273
crossref_primary_10_1007_s00203_021_02721_9
crossref_primary_10_3389_fmicb_2018_02405
crossref_primary_10_2174_2772434417666220912120726
crossref_primary_10_1080_21505594_2021_1980987
crossref_primary_10_1038_s41396_021_01179_3
crossref_primary_10_1128_aac_01102_23
crossref_primary_10_21307_PM_2020_59_3_19
crossref_primary_10_1007_s00232_018_0014_2
crossref_primary_10_3390_microorganisms8111793
crossref_primary_10_3389_fmicb_2018_03301
crossref_primary_10_1016_j_aquaculture_2023_739718
crossref_primary_10_3390_ijms20071781
crossref_primary_10_1128_IAI_00912_19
crossref_primary_10_1128_spectrum_02145_21
crossref_primary_10_3389_fmicb_2023_1139253
crossref_primary_10_1016_j_gene_2022_146295
crossref_primary_10_2174_0118715257267497231128093529
crossref_primary_10_2217_fmb_2019_0002
crossref_primary_10_3389_fmicb_2022_1041146
crossref_primary_10_1038_s41522_020_00178_0
crossref_primary_10_1128_spectrum_02311_22
crossref_primary_10_3389_fmicb_2021_705853
crossref_primary_10_1071_MA17046
crossref_primary_10_1016_j_micres_2022_127057
crossref_primary_10_3389_fcimb_2017_00055
crossref_primary_10_1016_j_aquaculture_2025_742258
crossref_primary_10_1038_nrmicro_2017_148
crossref_primary_10_1016_j_micres_2021_126722
crossref_primary_10_1016_j_crmicr_2024_100331
crossref_primary_10_1007_s00284_021_02407_x
crossref_primary_10_1038_s41564_018_0151_5
crossref_primary_10_1128_mBio_02338_20
crossref_primary_10_1371_journal_ppat_1008439
crossref_primary_10_1016_j_psj_2022_102388
crossref_primary_10_1128_msystems_00606_23
crossref_primary_10_3389_fmicb_2022_885092
crossref_primary_10_1080_21505594_2021_1950268
crossref_primary_10_1007_s44372_025_00092_9
crossref_primary_10_1128_AAC_01188_18
crossref_primary_10_1146_annurev_micro_020518_115714
crossref_primary_10_1128_JB_00565_20
crossref_primary_10_1128_IAI_00141_20
crossref_primary_10_1002_mbo3_1041
Cites_doi 10.1099/mic.0.026187-0
10.1093/infdis/jiu274
10.1128/mBio.01076-14
10.1046/j.1365-2958.2002.03170.x
10.1128/AAC.42.7.1529
10.1128/JB.186.20.6689-6697.2004
10.1128/iai.57.7.2136-2140.1989
10.1016/j.str.2015.12.009
10.1146/annurev.genet.41.042007.170548
10.1128/AAC.01132-06
10.1006/jmbi.1998.1985
10.1128/JB.00817-08
10.1128/JB.180.9.2442-2449.1998
10.1128/jb.172.11.6274-6281.1990
10.1128/jb.177.16.4696-4702.1995
10.1128/AAC.01433-06
10.1111/j.1574-6968.2011.02362.x
10.1126/science.1160354
10.1001/jama.2009.1754
10.1128/jb.147.1.255-258.1981
10.1097/CCM.0000000000000125
10.1093/nar/29.10.2003
10.1128/JB.01780-05
10.1038/nprot.2006.24
10.1128/jb.170.12.5971-5973.1988
10.1016/S0378-1119(98)00130-9
10.1146/annurev.biochem.69.1.183
10.1099/mic.0.049791-0
10.1128/AAC.03626-14
10.1128/IAI.02034-14
10.1073/pnas.83.20.7850
10.1128/JB.00917-10
10.1007/s12275-012-1555-1
10.1128/JB.00188-15
10.1016/0378-1119(90)90494-C
10.1086/533452
10.1111/j.1365-2958.1990.tb00681.x
10.1128/JCM.36.7.1938-1941.1998
10.1111/j.1574-6968.1980.tb05614.x
10.1016/j.febslet.2007.10.063
10.1016/j.ijantimicag.2015.03.001
10.3389/fmicb.2012.00148
10.1016/j.ijmm.2012.03.003
ContentType Journal Article
Copyright Copyright © 2017 American Society for Microbiology.
Copyright American Society for Microbiology Feb 2017
Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology
Copyright_xml – notice: Copyright © 2017 American Society for Microbiology.
– notice: Copyright American Society for Microbiology Feb 2017
– notice: Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology
DBID AAYXX
CITATION
NPM
7QL
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1128/JB.00705-16
DatabaseName CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate TCS Regulates Phase Variation in A. baumannii
EISSN 1098-5530
ExternalDocumentID PMC5237114
4305027231
27872182
10_1128_JB_00705_16
Genre Journal Article
Feature
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R21 AI115183
– fundername: HHS | National Institutes of Health (NIH)
  grantid: R21AI115183
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
186
18M
1VV
29J
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
79B
85S
8WZ
9M8
A6W
AAGFI
AAYXX
ABPPZ
ACGFO
ACGOD
ACNCT
ACPRK
ADBBV
ADXHL
AENEX
AFFDN
AFFNX
AFRAH
AGCDD
AGVNZ
AI.
AIDAL
AJUXI
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BKOMP
BTFSW
C1A
CITATION
CJ0
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
L7B
MVM
NHB
O9-
OHT
OK1
P-O
P-S
P2P
PQQKQ
QZG
RHI
RNS
RPM
RSF
RXW
TAE
TR2
UHB
UKR
UPT
VH1
W8F
WH7
WHG
WOQ
X7M
Y6R
YQT
YR2
YZZ
ZCA
ZCG
ZGI
ZXP
ZY4
~02
~KM
NPM
RHF
UCJ
VQA
YIN
7QL
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c372t-c23bf354d50abd04258a52350da3a6fe7cda671ff904e3eb2698e91171b898893
ISSN 0021-9193
1098-5530
IngestDate Thu Aug 21 14:07:49 EDT 2025
Fri Jul 11 08:41:53 EDT 2025
Fri Jul 11 12:12:48 EDT 2025
Mon Jun 30 08:15:15 EDT 2025
Wed Feb 19 02:43:32 EST 2025
Thu Apr 24 22:59:22 EDT 2025
Tue Jul 01 02:56:23 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords osmotic stress
Acinetobacter
phase variation
Language English
License Copyright © 2017 American Society for Microbiology.
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c372t-c23bf354d50abd04258a52350da3a6fe7cda671ff904e3eb2698e91171b898893
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Citation Tipton KA, Rather PN. 2017. An ompR-envZ two-component system ortholog regulates phase variation, osmotic tolerance, motility, and virulence in Acinetobacter baumannii strain AB5075. J Bacteriol 199:e00705-16. https://doi.org/10.1128/JB.00705-16.
OpenAccessLink https://jb.asm.org/content/jb/199/3/e00705-16.full.pdf
PMID 27872182
PQID 1860081552
PQPubID 40724
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5237114
proquest_miscellaneous_1868333384
proquest_miscellaneous_1842599606
proquest_journals_1860081552
pubmed_primary_27872182
crossref_primary_10_1128_JB_00705_16
crossref_citationtrail_10_1128_JB_00705_16
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-02-01
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of bacteriology
PublicationTitleAlternate J Bacteriol
PublicationYear 2017
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_36_2
Centers for Disease Control and Prevention (e_1_3_3_4_2) 2004; 53
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_44_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
17576842 - Antimicrob Agents Chemother. 2007 Sep;51(9):3431-3
17220422 - Antimicrob Agents Chemother. 2007 Apr;51(4):1530-3
9719640 - J Mol Biol. 1998 Sep 4;281(5):857-70
24813471 - J Infect Dis. 2014 Nov 1;210(9):1367-75
22752907 - J Microbiol. 2012 Jun;50(3):434-43
2121709 - J Bacteriol. 1990 Nov;172(11):6274-81
18076326 - Annu Rev Genet. 2007;41:121-45
25857949 - Int J Antimicrob Agents. 2015 Jun;45(6):568-85
11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45
17406227 - Nat Protoc. 2006;1(1):153-61
19952319 - JAMA. 2009 Dec 2;302(21):2323-9
26013481 - J Bacteriol. 2015 Aug 1;197(15):2593-9
25156738 - Infect Immun. 2014 Nov;82(11):4666-80
24394630 - Crit Care Med. 2014 May;42(5):1081-8
10966457 - Annu Rev Biochem. 2000;69:183-215
6263866 - J Bacteriol. 1981 Jul;147(1):255-8
22560766 - Int J Med Microbiol. 2012 Jul;302(3):117-28
17997983 - FEBS Lett. 2007 Dec 11;581(29):5573-8
24865555 - MBio. 2014 May 27;5(3):e01076-14
19383700 - Microbiology. 2009 Jun;155(Pt 6):1832-9
9661666 - Gene. 1998 May 28;212(1):77-86
25512405 - Antimicrob Agents Chemother. 2015 Feb;59(2):1236-45
2543631 - Infect Immun. 1989 Jul;57(7):2136-40
9650940 - J Clin Microbiol. 1998 Jul;36(7):1938-41
15466019 - J Bacteriol. 2004 Oct;186(20):6689-97
15549020 - MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6
22092679 - FEMS Microbiol Lett. 2011 Oct;323(1):44-51
16707665 - J Bacteriol. 2006 Jun;188(11):3731-9
20889755 - J Bacteriol. 2010 Dec;192(24):6336-45
1700256 - Mol Microbiol. 1990 Jul;4(7):1077-82
3020561 - Proc Natl Acad Sci U S A. 1986 Oct;83(20):7850-4
2185139 - Gene. 1990 Mar 1;87(1):45-51
26805524 - Structure. 2016 Feb 2;24(2):221-31
9573197 - J Bacteriol. 1998 May;180(9):2442-9
22536199 - Front Microbiol. 2012 Apr 23;3:148
9660978 - Antimicrob Agents Chemother. 1998 Jul;42(7):1529-36
18419525 - J Infect Dis. 2008 Apr 15;197(8):1079-81
3056929 - J Bacteriol. 1988 Dec;170(12):5971-3
19201803 - J Bacteriol. 2009 Apr;191(8):2834-42
7642497 - J Bacteriol. 1995 Aug;177(16):4696-702
21700662 - Microbiology. 2011 Sep;157(Pt 9):2534-44
12366850 - Mol Microbiol. 2002 Oct;46(1):281-91
18719281 - Science. 2008 Aug 22;321(5892):1078-80
References_xml – ident: e_1_3_3_19_2
  doi: 10.1099/mic.0.026187-0
– ident: e_1_3_3_22_2
  doi: 10.1093/infdis/jiu274
– ident: e_1_3_3_45_2
  doi: 10.1128/mBio.01076-14
– ident: e_1_3_3_18_2
  doi: 10.1046/j.1365-2958.2002.03170.x
– ident: e_1_3_3_40_2
  doi: 10.1128/AAC.42.7.1529
– ident: e_1_3_3_36_2
  doi: 10.1128/JB.186.20.6689-6697.2004
– ident: e_1_3_3_20_2
  doi: 10.1128/iai.57.7.2136-2140.1989
– ident: e_1_3_3_32_2
  doi: 10.1016/j.str.2015.12.009
– ident: e_1_3_3_13_2
  doi: 10.1146/annurev.genet.41.042007.170548
– ident: e_1_3_3_9_2
  doi: 10.1128/AAC.01132-06
– ident: e_1_3_3_39_2
  doi: 10.1006/jmbi.1998.1985
– ident: e_1_3_3_38_2
  doi: 10.1128/JB.00817-08
– ident: e_1_3_3_30_2
  doi: 10.1128/JB.180.9.2442-2449.1998
– ident: e_1_3_3_21_2
  doi: 10.1128/jb.172.11.6274-6281.1990
– ident: e_1_3_3_24_2
  doi: 10.1128/jb.177.16.4696-4702.1995
– ident: e_1_3_3_8_2
  doi: 10.1128/AAC.01433-06
– volume: 53
  start-page: 1063
  year: 2004
  ident: e_1_3_3_4_2
  article-title: Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004
  publication-title: Morb Mortal Wkly Rep
– ident: e_1_3_3_27_2
  doi: 10.1111/j.1574-6968.2011.02362.x
– ident: e_1_3_3_41_2
  doi: 10.1126/science.1160354
– ident: e_1_3_3_7_2
  doi: 10.1001/jama.2009.1754
– ident: e_1_3_3_15_2
  doi: 10.1128/jb.147.1.255-258.1981
– ident: e_1_3_3_10_2
  doi: 10.1097/CCM.0000000000000125
– ident: e_1_3_3_44_2
  doi: 10.1093/nar/29.10.2003
– ident: e_1_3_3_31_2
  doi: 10.1128/JB.01780-05
– ident: e_1_3_3_43_2
  doi: 10.1038/nprot.2006.24
– ident: e_1_3_3_17_2
  doi: 10.1128/jb.170.12.5971-5973.1988
– ident: e_1_3_3_42_2
  doi: 10.1016/S0378-1119(98)00130-9
– ident: e_1_3_3_12_2
  doi: 10.1146/annurev.biochem.69.1.183
– ident: e_1_3_3_26_2
  doi: 10.1099/mic.0.049791-0
– ident: e_1_3_3_35_2
  doi: 10.1128/AAC.03626-14
– ident: e_1_3_3_34_2
  doi: 10.1128/IAI.02034-14
– ident: e_1_3_3_16_2
  doi: 10.1073/pnas.83.20.7850
– ident: e_1_3_3_25_2
  doi: 10.1128/JB.00917-10
– ident: e_1_3_3_28_2
  doi: 10.1007/s12275-012-1555-1
– ident: e_1_3_3_11_2
  doi: 10.1128/JB.00188-15
– ident: e_1_3_3_23_2
  doi: 10.1016/0378-1119(90)90494-C
– ident: e_1_3_3_2_2
  doi: 10.1086/533452
– ident: e_1_3_3_14_2
  doi: 10.1111/j.1365-2958.1990.tb00681.x
– ident: e_1_3_3_5_2
  doi: 10.1128/JCM.36.7.1938-1941.1998
– ident: e_1_3_3_37_2
  doi: 10.1111/j.1574-6968.1980.tb05614.x
– ident: e_1_3_3_33_2
  doi: 10.1016/j.febslet.2007.10.063
– ident: e_1_3_3_3_2
  doi: 10.1016/j.ijantimicag.2015.03.001
– ident: e_1_3_3_6_2
  doi: 10.3389/fmicb.2012.00148
– ident: e_1_3_3_29_2
  doi: 10.1016/j.ijmm.2012.03.003
– reference: 9660978 - Antimicrob Agents Chemother. 1998 Jul;42(7):1529-36
– reference: 2121709 - J Bacteriol. 1990 Nov;172(11):6274-81
– reference: 22092679 - FEMS Microbiol Lett. 2011 Oct;323(1):44-51
– reference: 7642497 - J Bacteriol. 1995 Aug;177(16):4696-702
– reference: 9650940 - J Clin Microbiol. 1998 Jul;36(7):1938-41
– reference: 24865555 - MBio. 2014 May 27;5(3):e01076-14
– reference: 17576842 - Antimicrob Agents Chemother. 2007 Sep;51(9):3431-3
– reference: 26805524 - Structure. 2016 Feb 2;24(2):221-31
– reference: 19383700 - Microbiology. 2009 Jun;155(Pt 6):1832-9
– reference: 25512405 - Antimicrob Agents Chemother. 2015 Feb;59(2):1236-45
– reference: 22752907 - J Microbiol. 2012 Jun;50(3):434-43
– reference: 24394630 - Crit Care Med. 2014 May;42(5):1081-8
– reference: 26013481 - J Bacteriol. 2015 Aug 1;197(15):2593-9
– reference: 3056929 - J Bacteriol. 1988 Dec;170(12):5971-3
– reference: 25857949 - Int J Antimicrob Agents. 2015 Jun;45(6):568-85
– reference: 18419525 - J Infect Dis. 2008 Apr 15;197(8):1079-81
– reference: 15549020 - MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6
– reference: 19952319 - JAMA. 2009 Dec 2;302(21):2323-9
– reference: 20889755 - J Bacteriol. 2010 Dec;192(24):6336-45
– reference: 9661666 - Gene. 1998 May 28;212(1):77-86
– reference: 10966457 - Annu Rev Biochem. 2000;69:183-215
– reference: 12366850 - Mol Microbiol. 2002 Oct;46(1):281-91
– reference: 18719281 - Science. 2008 Aug 22;321(5892):1078-80
– reference: 22536199 - Front Microbiol. 2012 Apr 23;3:148
– reference: 6263866 - J Bacteriol. 1981 Jul;147(1):255-8
– reference: 17406227 - Nat Protoc. 2006;1(1):153-61
– reference: 16707665 - J Bacteriol. 2006 Jun;188(11):3731-9
– reference: 1700256 - Mol Microbiol. 1990 Jul;4(7):1077-82
– reference: 15466019 - J Bacteriol. 2004 Oct;186(20):6689-97
– reference: 2185139 - Gene. 1990 Mar 1;87(1):45-51
– reference: 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45
– reference: 24813471 - J Infect Dis. 2014 Nov 1;210(9):1367-75
– reference: 25156738 - Infect Immun. 2014 Nov;82(11):4666-80
– reference: 17997983 - FEBS Lett. 2007 Dec 11;581(29):5573-8
– reference: 21700662 - Microbiology. 2011 Sep;157(Pt 9):2534-44
– reference: 2543631 - Infect Immun. 1989 Jul;57(7):2136-40
– reference: 19201803 - J Bacteriol. 2009 Apr;191(8):2834-42
– reference: 17220422 - Antimicrob Agents Chemother. 2007 Apr;51(4):1530-3
– reference: 22560766 - Int J Med Microbiol. 2012 Jul;302(3):117-28
– reference: 3020561 - Proc Natl Acad Sci U S A. 1986 Oct;83(20):7850-4
– reference: 9719640 - J Mol Biol. 1998 Sep 4;281(5):857-70
– reference: 9573197 - J Bacteriol. 1998 May;180(9):2442-9
– reference: 18076326 - Annu Rev Genet. 2007;41:121-45
SSID ssj0014452
Score 2.498303
Snippet Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque...
Recently, a novel phase-variable colony opacity phenotype was discovered in strain AB5075, where colonies interconvert between opaque and translucent variants....
Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage E00705
SubjectTerms Acinetobacter
Acinetobacter baumannii
Bacteriology
Galleria mellonella
Genotype & phenotype
Gram-negative bacteria
Kinases
Motility
Mutation
Opacity
Osmosis
Protein folding
Sodium chloride
Title An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075
URI https://www.ncbi.nlm.nih.gov/pubmed/27872182
https://www.proquest.com/docview/1860081552
https://www.proquest.com/docview/1842599606
https://www.proquest.com/docview/1868333384
https://pubmed.ncbi.nlm.nih.gov/PMC5237114
Volume 199
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdgCIkXxP8VBjLSnkgDiRM7zmOLQFMRDE3dVPESOYmrRerSqmtB45vwbbmzE7eBDgF9iCrbSRzfz-e7s--OkEM1DYpYCukHJWd-LDHNixS5r2PNteSsTFP0d_74SRydxqMJn2zOqhrvklX-uvi-06_kf6gKZUBX9JL9B8q6h0IB_Af6whUoDNe_ovEAZL2LxYmv669fvPG3uY-ze17j9r6NRO4dL1eGvcEwmpzz-tL7fA4Ll3cGOrI92AFjfGyS-RTeeD7TmGjDWquhaNbkDEDr-lm1XBsPJWMiwf145AUY69nLFW4F1FWFm9wKq4cgAPJrBF97U9Wx54-Bddm-fLia6Y2B9cQIqBvLT7Nz1JgpYOkL3JEPbVkrRi7FJEUd3muzIzUgi3bzdIZ-CqMhRjnHsKliuxUQZHFhyMuA9WA4-s3C5o4btlU3yS0G2oTxCZ-4k0CgUnLWuG7Cu95svQlDRTf3duWW35SRX8_Ubgkp43vkbjPIdGChcp_c0PUDctvmG716SH4MauoAQzuAoRYwtAUMdYChBjDUAaZPG7hQB5c-bcHSpwAV6qBCq5p2oEIdVKiFCrVQeURO378bvz3ym9wcfhElbOUXLMqnEY9LHqi8RM4vFWcRD0oVKTHVSVEqkYTTaRrEOtI5E6nUsLAmYS5TCULyY7JXw_ftEwoaPugBRR4qieKlzKVSOoolLA4h5o_skVftyGdFE7geezjLjALLZDYaZoZiWSh65NA1Xth4LbubHbQkzJoJfZmFUqCEzDnrkZeuGtgt7qGpWs_X2AY-FSMaiT-1ETKCn4x75IlFhetLC6ceSTp4cQ0w3Hu3pq7OTdh3GN4kDOOn1z7zGbmzmXkHZG-1XOvnIDKv8hcG8D8BTirCbA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+ompR-envZ+Two-Component+System+Ortholog+Regulates+Phase+Variation%2C+Osmotic+Tolerance%2C+Motility%2C+and+Virulence+in+Acinetobacter+baumannii+Strain+AB5075&rft.jtitle=Journal+of+bacteriology&rft.au=Tipton%2C+Kyle+A&rft.au=Rather%2C+Philip+N&rft.date=2017-02-01&rft.eissn=1098-5530&rft.volume=199&rft.issue=3&rft_id=info:doi/10.1128%2FJB.00705-16&rft_id=info%3Apmid%2F27872182&rft.externalDocID=27872182
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9193&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9193&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9193&client=summon